In our study, we also observed that HCC patients with elevated plasma IL-6 and CRP levels tended to have more advanced disease according to the BCLC staging system and a higher incidence of MVI, suggesting a positive correlation between circulating IL-6 and CRP levels and HCC progression. This evidence concerns the gene CRP and hepatocellular carcinoma.